Biogen Idec U S Corporation is categorized under Wholesale Pharmaceutical Products in Cambridge, MA and active since 2001.
Biogen Idec U S Corporation was established in 2001, and today employs 1 to 4, earning Unknown per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact George A Scangos at the company’s headquarters by writing to 14 Cambridge Center, Cambridge, Massachusetts MA 02142 or by phoning (617) 679-2000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Biogen Idec U S Corporation |
| Contact Person: | George A Scangos |
| Address: | 14 Cambridge Center, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 679-2000 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2001 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Biogen Idec U S Corporation was started in 2001 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact George A Scangos for inquiries that concern Biogen Idec U S Corporation by calling the company number (617) 679-2000, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Biogen Idec U S Corporation can be found at the coordinates 42.364544,-71.088253 as well as the street address 14 Cambridge Center in Cambridge, Massachusetts 02142.
For its online presence, you may visit Biogen Idec U S Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.